ETF Trends editor Tom Lydon appeared on CNBC Wednesday to discuss how investors can utilize biotechnology ETFs to capture some of the greater merger and acquisition activity taking place in the healthcare space.
Watch the video below to see the full interview.
To view past video interviews, visit our video section.